Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary splenic diffuse large B-cell lymphoma presenting as a splenic abscess. | EJHaem | 2023 | 36819150 | PubTator, text mining | PubMed |
| Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions. | Front Pharmacol | 2023 | 36817143 | PubTator, text mining | PubMed |
| Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy. | Cancer Med | 2023 | 36812122 | PubTator, text mining | PubMed |
| Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography-mass spectrometry (LC-MS/MS). | J Neurooncol | 2023 | 36811765 | PubTator, text mining | PubMed |
| Tracheostomy in children is associated with neutrophilic airway inflammation. | Thorax | 2023 | 36808087 | PubTator, text mining | PubMed |
| The initial interplay between HIV and mucosal innate immunity. | Front Immunol | 2023 | 36798134 | PubTator, text mining | PubMed |
| Site-specific encoding of photoactivity and photoreactivity into antibody fragments. | Nat Chem Biol | 2023 | 36797401 | PubTator, text mining | PubMed |
| Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. | Front Genet | 2023 | 36793897 | PubTator, text mining | PubMed |
| [Lung Squamous Cell Carcinoma with EML4-ALK Fusion and TP53 Co-mutation Treated with Ensartinib: A Case Report and Literature Review]. | Zhongguo Fei Ai Za Zhi | 2023 | 36792084 | PubTator, text mining | PubMed |
| Correlation analysis between immune-related genes and cell infiltration revealed prostate cancer immunotherapy biomarkers linked to T cells gamma delta. | Sci Rep | 2023 | 36774376 | PubTator, text mining | PubMed |
| Enabling Single-Cell Drug Response Annotations from Bulk RNA-Seq Using SCAD. | Adv Sci (Weinh) | 2023 | 36762572 | PubTator, text mining | PubMed |
| The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causation. | Front Immunol | 2023 | 36756132 | PubTator, text mining | PubMed |
| A mechanistic evaluation of human beta defensin 2 mediated protection of human skin barrier in vitro. | Sci Rep | 2023 | 36755116 | PubTator, text mining | PubMed |
| Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET. | Cell Rep Med | 2023 | 36754052 | PubTator, text mining | PubMed |
| Diagnosis and Management of Cystic Fibrosis Exacerbations. | Semin Respir Crit Care Med | 2023 | 36746183 | PubTator, text mining | PubMed |
| Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 36742380 | PubTator, text mining | PubMed |
| Ribosome rescue factor PELOTA modulates translation start site choice and protein isoform levels of transcription factor C/EBPα. | bioRxiv | 2023 | 36711859 | PubTator, text mining | PubMed |
| A DUAL MTOR/NAD+ ACTING GEROTHERAPY. | bioRxiv | 2023 | 36711589 | PubTator, text mining | PubMed |
| A hierarchical pathway for assembly of the distal appendages that organize primary cilia. | bioRxiv | 2023 | 36711481 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma. | Cell Mol Gastroenterol Hepatol | 2023 | 36708970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=23